Inventor · disambiguated record
Rickey Robert Reinhardt
Also filed as: REINHARDT RICKEY · REINHARDT RICKEY ROBERT
1 granted patent·11 pending applications·1 citations·filing 2017–2025
17Inventor score
Top patents by PatentIndex Score
12 records- 0172US2024254214A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0271US11613739B2Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cellsREGENXBIO INC·Filed 2018·Granted Mar 28, 2023·1 cites·16 claims
- 0367US2025051740A1Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cellsREGENXBIO INC·Filed 2024·Application pending·0 cites
- 0466US2023057519A1Treatment of Ocular Diseases with Fully-Human Post-Translationally Modified Anti-VEGF FabREGENXBIO INC·Filed 2022·Application pending·0 cites
- 0564US2025320287A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2025·Application pending·0 cites
- 0663US2024050537A1Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)REGENXBIO INC·Filed 2023·Application pending·0 cites
- 0756US2019211091A1Treatment of Ocular Diseases with Fully-Human Post-Translationally Modified Anti-VEGF FabREGENXBIO INC·Filed 2019·Application pending·0 cites
- 0855US2020277364A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2018·Application pending·0 cites
- 0950US2019127455A1Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF FabREGENXBIO INC·Filed 2017·Application pending·0 cites
- 1047US2019358303A1Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)REGENXBIO INC·Filed 2018·Application pending·0 cites
- 1146US2024115732A1Epicardial Delivery of Gene TherapyXYLOCOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1240US2021275647A1Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)REGENXBIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rickey Robert Reinhardt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →